Indication
Relapsing polychondritis
Relapsing polychondritis is a rare, systemic autoimmune disease characterized by recurrent, progressive inflammation and destruction of cartilaginous structures and proteoglycan-rich tissues throughout the body. Read more about Relapsing polychondritis
57 drugs 51 manufacturers
Drugs that treat it
Common Relapsing polychondritis therapies.
PREDNISONE
RAYOS (prednisone)
PREDNISONE
PREDNISONE
PREDNISONE
PREDNISONE
PREDNISONE
PREDNISONE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonRelapsing polychondritis is a rare, systemic autoimmune disease characterized by recurrent, progressive inflammation and destruction of cartilaginous structures and proteoglycan-rich tissues throughout the body.
It most frequently develops in adults between the fourth and sixth decades of life, presenting with hallmark episodic inflammation of the external ears (auricular chondritis typically sparing the noncartilaginous lobule), nasal cartilage resulting in saddle nose deformity, and peripheral joints.
Pathophysiologically driven by an immune-mediated degradation of cartilage matrix proteins, the condition can also cause life-threatening complications, including tracheobronchial collapse, sensorineural hearing loss, ocular inflammation, and cardiovascular involvement.
- nih.gov
Relapsing polychondritis is a rare, systemic autoimmune disease characterized by recurrent, progressive inflammation and destruction of cartilaginous structures and proteoglycan-rich tissues throughout the body It most frequently develops in adults between the fourth and sixth decades of life, presenting with hallmark episodic inflammation of the external ears (auricular chondritis typically sparing the noncartilaginous lobule), nasal cartilage resulting in saddle nose deformity, and peripheral ...
- nih.gov
Relapsing polychondritis is a rare, systemic autoimmune disease characterized by recurrent, progressive inflammation and destruction of cartilaginous structures and proteoglycan-rich tissues throughout the body Pathophysiologically driven by an immune-mediated degradation of cartilage matrix proteins, the condition can also cause life-threatening complications, including tracheobronchial collapse, sensorineural hearing loss, ocular inflammation, and cardiovascular involvement
- nih.gov
Relapsing polychondritis is a rare, systemic autoimmune disease characterized by recurrent, progressive inflammation and destruction of cartilaginous structures and proteoglycan-rich tissues throughout the body
- nih.gov
It most frequently develops in adults between the fourth and sixth decades of life, presenting with hallmark episodic inflammation of the external ears (auricular chondritis typically sparing the noncartilaginous lobule), nasal cartilage resulting in saddle nose deformity, and peripheral joints
- pennmedicine.org
It most frequently develops in adults between the fourth and sixth decades of life, presenting with hallmark episodic inflammation of the external ears (auricular chondritis typically sparing the noncartilaginous lobule), nasal cartilage resulting in saddle nose deformity, and peripheral joints
Personalize your experience
Follow Relapsing polychondritis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.